Taysha Gene Therapies, Inc. short interest in 2024
In 2024, Taysha Gene Therapies, Inc.'s disclosed short interest ran from 9.35% of shares outstanding on 12 Jan 2024 to 12.63% on 31 Dec 2024, a change of +3.28 percentage points. The year's high was 12.63% on 31 Dec 2024 and its low 7.19% on 28 Jun 2024, averaging 9.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.68 days on 30 Aug 2024. Full history: Taysha Gene Therapies, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 9.35% (12 Jan 2024)
- End of year
- 12.63% (31 Dec 2024)
- Change
- +3.28 pp
- High
- 12.63% (31 Dec 2024)
- Low
- 7.19% (28 Jun 2024)
- Average
- 9.32%
- Highest days to cover
- 24.68 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 9.35% | 7.23 | |
| 31 Jan 2024 | 8.98% | 15.10 | |
| 15 Feb 2024 | 8.72% | 13.40 | |
| 29 Feb 2024 | 7.43% | 2.78 | |
| 15 Mar 2024 | 8.46% | 8.23 | |
| 28 Mar 2024 | 9.08% | 2.81 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 8.59% | 7.61 | |
| 30 Apr 2024 | 9.04% | 11.97 | |
| 15 May 2024 | 9.11% | 10.06 | 10-Q filed, results (8-K) |
| 31 May 2024 | 8.62% | 9.95 | |
| 14 Jun 2024 | 7.87% | 6.54 | |
| 28 Jun 2024 | 7.19% | 1.70 | results (8-K) |
| 15 Jul 2024 | 11.13% | 11.71 | |
| 31 Jul 2024 | 12.41% | 17.41 | |
| 15 Aug 2024 | 10.14% | 15.02 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 10.57% | 24.68 | |
| 13 Sep 2024 | 9.67% | 14.97 | |
| 30 Sep 2024 | 10.07% | 9.26 | |
| 15 Oct 2024 | 10.10% | 13.74 | |
| 31 Oct 2024 | 8.61% | 11.01 | |
| 15 Nov 2024 | 7.69% | 1.71 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 7.65% | 2.36 | |
| 13 Dec 2024 | 10.68% | 4.76 | |
| 31 Dec 2024 | 12.63% | 10.66 |
See also: Taysha Gene Therapies, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.